Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3651_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
51 Мб
Скачать
Contributors
https://t.me/medicina_free
xxiii
ThomasRobein
Biosense Webster, Mulhouse, France
Johnson & Johnson, Mulhouse, France
OlivierRoth, MD
Cardiology Department, “Emile Muller” Hospital, Mulhouse, France
SerbanSchiau, MD
Cardiology Department, “Emile Muller” Hospital, Mulhouse, France
xxiv
https://t.me/medicina_free
BergamotteThinotSerbanSchiau, MD
Biosense Webster, Mulhouse, France
MaximTissier
Contributors
Biosense Webster, Mulhouse, France
Johnson & Johnsson, Mulhouse, France
Jean-YvesWiedemann, MD
Cardiology Department, “Emile Muller” Hospital, Mulhouse, France
Abbreviations
https://t.me/medicina_free
AF Atrial brillation AP Antero-posterior ASD Atrial septal defect AT Atrial tachycardia AV Atrio-ventricular AVN Atrio-ventricular node AVNRT Atrio-ventricular node reentry tachycardia AVRT Atrio-ventricular reentry tachycardia BMI Body mass index BP Blood pressure BUN Blood urea nitrogen CABG Coronary artery bypass graft CFAE Complex fractionated atrial electrograms COPD Chronic obstructive pulmonary disease cTnI Cardiac troponin I CX Circumex (coronary artery) EDD End diastolic diameter EF Ejection fraction EP Electrophysiology EPS Electrophysiological study ESD End systolic diameter Hb Hemoglobin Hct Hematocrit HFpEF Heart failure with preserved ejection fraction HFrEF Heart failure with reduced ejection fraction HR Heart rate ICD Implantable cardioverter debrillator ISV Internal saphenous vein IVC Inferior vena cava IVS Interventricular septum LA Left atrium LAD Left anterior descending (coronary artery) LAO Left anterior oblique LBBB Left bundle branch block LIMA Left internal mammary artery LPSV Left superior pulmonary vein LIPV Left inferior pulmonary vein
xxv
xxvi
https://t.me/medicina_free
LL Left lateral LV Left ventricle MI Myocardial infarction NT-pro BNP N-terminal pro-brain natriuretic peptide ORT Orthodromic reciprocating tachycardia PA Postero-anterior PAC Premature atrial contraction PAF Paroxysmal atrial brillation PFO Patent foramen ovale PV Pulmonary vein PVC Premature ventricular contraction RA Right atrium RAO Right anterior oblique RBBB Right bundle branch block RCA Right coronary artery RIMA Right internal mammary artery RL Right lateral RSPV Right superior pulmonary vein RIPV Right inferior pulmonary vein RV Right ventricle SCD Sudden cardiac death sPAP Systolic pulmonary artery pressure SVC Superior vena cava TAPSE Tricuspid annulus plane systolic excursion TSH Thyroid stimulating hormone VT Ventricular tachycardia WPW Wolf-Parkinson-White
Abbreviations
Case 1
https://t.me/medicina_free
RonanLe Bouar, FrédéricHalbwachs, JacquesLevy, Jean-YvesWiedemann, CrinaMuresan, andLaurentDietrich
1
Case Presentation
A 45-year-old female patient with no signicant past medical history was diagnosed by her family physician with an irregular pulse. The patient had been complaining of dyspnea on exertion that had progressively aggravated during the past sev­eral months. A cardiology consultation was orga­nized and performed, which diagnosed frequent, predominantly monomorphic PVC, with a high ventricular arrhythmia burden at 24-h Holter ECG (50,017 PVC, of which 46,435 isolated PVC, 1838 couplets, and 2 runs, representing
36.7% of the total QRS complexes/24h). Her 12-lead ECG is presented in Fig.1.1. The
result of her 24-h Holter ECG is presented in Fig.1.2.
Her transthoracic echocardiography demon-
strated severe LV systolic dysfunction (LVEF of 30%). She was referred to the cardiology depart­ment for detailed cardiovascular investigations and treatment. Her cardiovascular risk factors
R. Le Bouar (*) · J. Levy · J.-Y. Wiedemann · C. Muresan · L. Dietrich Cardiology Department, “Emile Muller” Hospital, Mulhouse, France e-mail: LEBOUARR@ghrmsa.fr; levyj@ghrmsa.fr;
wiedemannjy@ghrmsa.fr; crina.muresan@ghrmsa.fr; laurent.dietrich@ghrmsa.fr
F. Halbwachs Biosense Webster, Mulhouse, France
were represented by active smoking. Her medica­tion at home consisted of bisoprolol 2.5mg, pre­scribed by her cardiologist.
Her transthoracic echocardiography showed severe LV systolic dysfunction, with an EF% of 26% (Fig.1.3). It also showed global hypokine­sia, with a dilated LV (EDD of 63 mm), non­elevated LV lling pressure, cardiac index of
2.9 L/min/m2, mild aortic regurgitation, non­dilated left atrium, non-dilated right ventricle, mild tricuspid regurgitation, absence of pulmo­nary hypertension, sPAP of 33 mmHg, and absence of pericardial effusion.
An exercise stress test did not show any signs of myocardial ischemia. It demonstrated disap­pearance of PVCs during effort, with reappear­ance after the end of the effort.
Given the ECG aspect of the PVC, suggesting an origin in the RVOT, a cardiac MRI was per­formed, searching for arguments in favor of arrhythmogenic cardiomyopathy (Fig.1.4).
Her biological workup showed a Hb level of
12.1 g/dL, leukocytes 4.81 × 109/L, platelets 214×109/L, CRP<3mg/L, BUN 4.5mmol/L, creatinine 68μmol/L, glycemia 4.5mmol/L, Na+ 141 mmol/L, K+ 3.7 mmol/L, NT pro-BNP 1080pg/mL, and TSH 2.3IU/L.
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 L. Muresan (ed.), Clinical Cases in Cardiac Electrophysiology: Ventricular Arrhythmias,
https://doi.org/10.1007/978-3-031-35579-0_1
1
2
https://t.me/medicina_free
R. Le Bouar et al.
Fig. 1.1 A 12-lead ECG at admittance to the cardiology department
Question 1: Where is the origin of the PVCs presented in Fig. 1.1?
A. RVOT B. LVOT
Question 3: Is there a possible relation-
ship between the PVCs and the systolic
LV dysfunction?
A. Yes. The PVCs are the most likely cause
C. LV summit D. Right coronary cusp
B. Yes. The severe systolic dysfunction
E. Left coronary cusp
C. No. This is a simple coincidence.
D. No. Both are expression of the same
Question 2: How would you consider the
E. I don’t know.
ventricular arrhythmia burden of this patient on the 24-h Holter ECG?
A. Insignicant. B. Mild. C. Moderate. D. Important. E. I don’t know.
Question 4: What is the best treatment
option for this patient’s PVCs?
A. Beta blockers
B. Flecainide
C. Amiodarone
D. Sotalol
E. Catheter ablation
of the LV systolic dysfunction.
determined the appearance of PVCs.
unidentied inherited arrhythmia syndrome.
1 Case 1
https://t.me/medicina_free
3
Fig. 1.2 A 24-hour Holter ECG recording showing frequent, predominantly monomorphic PVC, with a high ventricu­lar arrhythmia burden, representing 36.7% of the total QRS complexes/24h
4
https://t.me/medicina_free
R. Le Bouar et al.
Fig. 1.3 Left panel: Echocardiography image in apical four-chamber view, showing a severely depressed LV EF% of 26% (quantied by Simpson single-plane
60 mm
Fig. 1.4 Left panel: Cardiac MRI image (cine SSFP four-chamber view) showing an end-diastolic diameter of 60mm and no global or localized dilation of the right ven­tricle. Right panel: Three-chamber view showing absence
method). Right panel: Echocardiography image in apical two-chamber view, showing a severely depressed LV 31 EF% (quantied by Simpson biplane method)
of late gadolinium enhancement at the level of the right and left ventricle. No major or minor criteria in favor of arrhythmogenic cardiomyopathy
1 Case 1
https://t.me/medicina_free
5
Figure 1.1 explained. A 12-lead ECG show­ing sinus rhythm with a heart rate of 84bpm, QRS axis at +60°, absence of LV hypertrophy, absence of ischemia, frequent monomorphic PVC, and one polymorphic ventricular couplet, normal QT interval. The PVC morphology is “QS” in lead I, “R” in leads II, III, and aVF with LBBB morphol­ogy, and a precordial transition in V4, in favor of a RVOT origin. Of note, the PVC QRS transition in precordial leads (V4) takes place later than the QRS transition in sinus rhythm (V3), argument in favor of a RVOT origin.
Given the high arrhythmia burden demon­strated by the 24-h Holter ECG (more than 26,000/24h) and the likely arrhythmic cause of her dilated cardiomyopathy (no structural abnormality was found by transthoracic echocar­diography, coronary angiography, and cardiac MRI), a catheter ablation procedure was offered and accepted by the patient. Of note, long-term antiarrhythmic drugs were not desired by the patient.
Electrophysiological Study andRF Catheter Ablation Procedure
The ablation procedure was performed under local anesthesia and conscious sedation. Vascular access was obtained using the modied Seldinger technique, under Doppler ultrasound guidance. A 6F bipolar non-steerable catheter (Viking, Boston Scientic®) was introduced in a 6F 20cm vascu­lar sheath and was subsequently advanced via the right common femoral vein up to the right ven­tricular apex. A Biosense Webster SF open-irrigated 3.5mm tip with double curve D/F was used as the roving/ablation catheter, which was introduced in a 9F 20 cm vascular sheath at the level of the right common femoral vein and advanced at the level of the right ventricle.
The CARTO® 3 electro-anatomic mapping system (Biosense Webster, Johnson & Johnson) was used to guide mapping and ablation of the accessory pathway.
®
SmartTouch
6
https://t.me/medicina_free
R. Le Bouar et al.
Ventricular pacing was carried out at twice the diastolic threshold using the EP-4™ Cardiac Stimulator (Abbott®) system. Surface ECG and intracavitary ECGs were recorded by the WorkMate Claris™ System (Abbott®).
Given the 12-lead aspect of the PVC (“QS” in lead I, “R” in leads II, III, and aVF with a LBBB morphology, and a precordial transition in V4), an origin at the level of the RVOT was suspected. Mapping of the PVC was therefore commenced in the RVOT.
An anatomical map of the RVOT was initially created.
Next, an activation map of the RVOT during the frequent PVCs was created. This showed the
presence of an early activation site at the level of the high posterior and lateral RVOT, just below the pulmonary valve, from where the activation of the RVOT spread in a radial manner, suggest­ing a focal activation pattern (Fig.1.5). The local bipolar electrogram preceded the onset of the QRS complex on the surface ECG by 17ms. At this site, the unipolar electrogram recorded by the roving/ablation catheter had a “QS” aspect.
A pacemap was subsequently created by pac­ing from the distal electrode of the roving/abla­tion catheter at a xed coupling interval of 600ms in several areas of the RVOT, with empha­sis on the area of the earliest activation during the PVCs. The PASO module of the CARTO system
Fig. 1.5 CARTO image of the right ventricular outow tract (RVOT) in left lateral view 100°. Activation map of the RVOT during PVCs, showing an area of early endo­cardial activation, preceding the onset of the QRS onset on the surface ECG, with a “QS” aspect of the local uni­polar electrogram. The area is situated in the upper lateral and slightly posterior part of the RVOT.The orange dots
represent the bundle of His. The right part of the image shows the 12-lead ECG, together with the distal bipolar electrode of the ablation catheter (MAP 1–2) and the uni­polar recording of the distal electrode (MAP 1). The uni­polar electrogram recorded by the ablation catheter has a “QS” aspect